Metastatic Malignant Neoplasm to the Leptomeninges Recruiting Phase Trials for Pemetrexed (DB00642)

Also known as: Leptomeningeal Metastasis / Neoplastic Meningitis / Leptomeningeal Metastases / Metastatic Malignant Neoplasm in the Leptomeninges / Leptomeningeal Disease (LMD) / Leptomeningeal Disease / Lymphomatous meningitis / Leptomeningeal Carcinomatosis / Metastatic malignant neoplasm to leptomeninges (disorder) / Lymphomatous meningitis (disorder) / Malignant meningitis (disorder) / Leptomeningeal Neoplasms / Meningeal dissemination / Metastases to meninges / Meningeal Carcinomatosis

DBCOND0057483 (Metastatic Malignant Neoplasm to the Leptomeninges)RecruitingNot Available IdentifierTitlePurposeDrugs
NCT06399926Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir
NCT06304441Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung CancerTreatment
NCT05305885Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal MetastasisTreatment